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Abstract
This report describes the clinical, radiological, microscopical and ligandohis-
tochemical findings in a 17-year-old woman who suffered from an acute onset
of pulmonary hemosiderosis after inhalation of pesticides used for the cultiva-
tion of strawberries. She complained of headache, dyspnea, rhinitis, weakness
and recurrent severe hemoptysis. Chest radiographs revealed bilateral patchy
infiltrates, predominantly in the lower parts of both lungs. The consecutive
severe anemia was treated by multiple blood transfusions which were repeated
every 4–5 days. Open lung biopsies displayed signs of diffuse hemorrhage with
hemosiderin-loaded macrophages, some hyaline membranes, focal fibroid
deposits with intermingled histiocytes, mild interstitial fibrosis and focal
intra-alveolar calcified bodies surrounded by foreign body giant cells. Analysis
of endogenous lectins failed to demonstrate expression of binding capacities
for maltose, fucose, mannose, lactose and sialic acid. Neither binding capaci-
ties for the macrophage-migration-inhibitory factor nor its presence, as ana-
lyzed by labeled sarcolectin, could be detected histochemically. The light
microscopical findings are consistent with a longer-lasting diffuse pulmonary
hemosiderosis; the presence of calcified bodies and foreign body giant cells
(including the ligandohistochemical data) argues for a causal role of inhaled
substances. The patient’s clinical course improved after cyclophosphamide
treatment, which restored her ability to work and released her from the need
for recurrent blood transfusions.
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Introduction
Diffuse pulmonary hemosiderosis is histologically de-
fined by inflammatory alterations of the lung parenchy-
ma, associated with increased intrapulmonary deposits of
hemosiderin [1–3]. Its major clinical manifestation is dif-
fuse pulmonary hemorrhage [4–9]. It is a rare disease
which is seen in children and young adults (up to 30 years
of age); adults are less frequently affected. Most of the
described cases have been reported without mentioning
exposure to causative or associated agents, and the disease
is commonly listed in textbooks under the term of idio-
pathic pulmonary hemosiderosis [10, 11]. Reactivity for
antiglomerular basement membrane antibody is usually
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absent, as well as clinical signs of glomerulonephritis or
related diseases [12, 13]. A few authors reported associa-
tions of pulmonary hemosiderosis with gluten-sensitive
enteropathy or hypersensitivity against cow’s milk (Heif-
er’s syndrome) [14–18]. Elevated serum IgA levels are
found in about 50% of the patients [3, 6, 19]. Among
exogenous substances described to be associated with dif-
fuse pulmonary hemosiderosis, exposure to large amounts
of trimellitic anhydride has been reported [20]. This sub-
stance is used in the plastic-producing industry, and ele-
vated serum levels of this substance could be demon-
strated in exposed workers [20]. The course of the disease
is usually poor, especially in young children, whereas
young adults have a reasonable prognosis [3, 10]. We here
report the clinical, radiological and histopathological
findings of a young female patient. The characteristics of
her disease are related to the features of an idiopathic pul-
monary hemosiderosis and associated with the exposure
to pesticides.
Case Presentation and Findings
This 17-year-old woman was living in a farmer’s family and
involved in the daily work of a small family farm, including the culti-
vation of strawberries. Until the onset of her disease, neither severe
disorders nor a genetic family burden had been reported. She was a
HIV-negative nonsmoker with no history of alcohol or other drug
abuse at the time when she sprayed and inhaled for about 6 hours the
following substances during cultivation of strawberries in summer
time (July): (1) DECIS (deltamethrin [(S)·-cyano-3-phenoxyben-
zyl (1R,3R)-3- (2,2-dibromvinyl ) -2,2-dimethylcyclopropanecarbox-
ylate], synthetic peritroids, class IV of toxicity); (2) BANKOL (ben-
sultap, tiosulfonians, class III of toxicity), and (3) KARATE (lambda-
cyhalothrin[·-cyano-3- phenoxybenzyl -3- (2-chlor-3,3,3-trifluoro-
prop-1-enyl)-2,2-dimethylcyclopropanecarboxylate], class III of tox-
icity). About 4 days later, she developed dyspnea, rhinitis, weakness
and moderate hemoptysis and was admitted to a regional hospital
and afterwards referred to the Institute of Tuberculosis and Lung
Diseases in Warsaw. Upon admission to the Institute, she was pale
and tired, with dyspnea on minimal exertion. Bilateral inspiratory
rales were found on both lungs. Digital clubbing was absent. Chest
X-rays revealed bilateral patchy infiltrations, predominantly in the
lower parts of both lungs (fig. 1). Laboratory data included: hemoglo-
bin concentration 8 g/dl, red blood cell count 2,390,000/mm3, in-
cluding 75% reticulocytes, and leukocyte count 6,600/mm3, with
normal subpopulations (eosinophiles 2%). Coombs test was negative.
Neither antinuclear antibodies nor antibodies against the cytoplasm
of granulocytes were found. Urine and stool analyses were without
pathological findings. The following serum levels were defined: total
protein 6.1 g/dl, albumin 67.9%, ·-1 globulin 2.8%, ·-2 globulin
8.4%, ß-globulin 10.4%, Á-globulin 10.5%, blood creatinine 0.7 mg/
dl, glutamic-oxaloacetic transaminase 26 U/l, glutamic pyruvic
transaminase 9 U/l, alkaline phosphatase 32 U/l, bilirubin 0.7 mg/dl
and iron 46 ng/dl. Routine blood gas analysis revealed mild function-
al abnormalities including a PaO2 of 60.8 mm Hg, pH 7.45, and
Fig. 1. Chest radiograph showing diffuse dense infiltrates of both
lungs, predominantly in the lower parts.
PaCO2 of 32.6 mm Hg. At bronchoscopy, a severe mucosanguineous
secretion was seen within the otherwise normal major bronchi. Anal-
ysis of the bronchoalveolar lavage fluid revealed numerous hemosi-
derin-loaded macrophages. After performance of a wedge biopsy (see
below), the patient was treated with prednisone (1 mg/kg, equivalent
to a daily dose of 50 mg). During this treatment, she continued to
experience hemoptysis and required blood transfusions every 4–5
days. After 14 days, azathioprine (100 mg/day) was added to the
prednisone treatment; however, no improvement was noted. After 4
weeks, the treatment included cyclophosphamide (2 mg/kg) in addi-
tion to prednisone. Thereafter, a constant improvement of her health
condition was seen. After discharge, she continued to be treated with
cyclophosphamide 1,000 mg intravenously once every 6 weeks and
prednisone at a dosis of 15 mg every second day. Blood transfusions
were no longer needed. She was feeling well and went back to work.
Physical examinations of her chest were normal, although her chest
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Fig. 2. Microphotograph showing the still preserved lung texture
and a marked hyperplasia and dysplasia of the cells of the alveolar
lining. HE. !185.
Fig. 3. Microphotograph showing hemosiderin-loaded macro-
phages, a marked desquamation of the cells of the alveolar lining and
hemosiderin deposits in the walls of small arteries and veins. Prus-
sian blue. !185.
X-rays still demonstrated diffuse infiltrations. These were less pro-
nounced after therapy compared to the initial X-rays. Her hemoglo-
bin level increased to 13 g/dl, the erythrocyte count to 3,900,000/
mm3, and the blood gas analysis showed a PaO2 of 77.3 mm Hg, a pH
of 7.4 and PaCO2 of 35 mm Hg.
Pathohistological Findings
The lung parenchyma taken by an open lung biopsy (wedge biop-
sy) displayed signs of a longer-lasting intrapulmonary hemorrhage
with still preserved lung texture, focal calcified bodies, including a
few foreign body giant cells, and altered cells of the alveolar lining
(fig. 2). The inflammatory infiltrates were weak and consisted of lym-
phocytes and plasma cells. Hemosiderin-loaded macrophages were
the predominant feature (fig. 3). Some areas displayed small hyaline
membranes and fibroid deposits with intermingled histiocytes; in
addition, some fibroid plugs could be noted in the small bronchi
(110th generation). The pneumocytes appeared hyperplastic and
dysplastic, whereas the texture of the vascular system (arteries and
veins) was of normal configuration. There was already a moderate
focal interstitial fibrosis (fig. 4). Application of neoglycoproteins
failed to detect fucose-, maltose-, mannose- and sialic-acid-specific
binding capacities. No expression of IgA, IgG or IgE could be
detected immunohistochemically. However, a disturbance of the cel-
lular immune system appeared to exist, as inferable by a lack of pres-
ence of macrophage-migration-inhibitory factor (MIF), probed ligan-
dohistochemically by biotinylated sarcolectin, and of MIF-binding
sites. These findings were in agreement with data reported from lung
involvement in autoimmune disorders [21–23].
Pesticide-Exposure-Associated
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Fig. 4. Microphotograph showing an already moderate intersti-
tial fibrosis (birefringent areas). Sirius-red. !155.
Discussion
Pulmonary hemosiderosis is a rare disease, usually
seen in children, with an estimated incidence of about 2
out of 100,000 children/year [3, 15]. Most of the affected
children die within 2–5 years after clinical diagnosis. It
can also occur in young adults, who have a more favorable
prognosis, with intermittent silent periods lasting for up
to 20 years between two attacks of the disease. The clini-
cal history is not characterized by distinct features. Most
frequently, there is a mild onset of cough, lethargy and
dyspnea, with increasing tendency for a few months
before the patients ask for medical examination. Hemop-
tysis is rather rare. In 20–50% of the patients, blood eosin-
ophilia can be observed, and elevated IgA levels have
been reported to occur in about 50% of the patients [3].
The clinical history of the presented patient was char-
acterized by a sudden onset of dyspnea and moderate
hemoptysis occurring a few days after exposure to the
above-listed pesticides. The serum levels of the analyzed
immunoglobulin classes and enzymes were within the
normal range. Autoantibodies or other abnormalities of
the immune system could not be detected. The chest
radiographs displayed cloudy densities in both lower
lobes, which could either be related to the primary source
of bleeding or to aspirated blood. The leading symptom
was recurrent hemoptysis, which needed multiple blood
transfusions every 4–5 days. Therapy with prednisone
(50 mg/day) was not effective, and only the additional
application of cyclophosphamide could stop the bleedings
and improve the clinical course.
The light-microscopical findings are characteristic for
hemosiderosis: preserved lung parenchyma with some
interstitial inflammatory infiltrates, agglutinations of he-
mosiderin-loaded macrophages within the alveoli, hyper-
plasia and dysplasia of the alveolar lining cells, focal fibrin
deposits and a mild to moderate interstitial diffuse fibro-
sis. The absence of carbohydrate-binding proteins in the
pneumocytes is in agreement with the hypothesis of a
noninfectious disease [21–23], as corroborated by the
immunohistochemical findings of a disturbance of the
cellular immune system within the lung assessed by the
absence of MIF and MIF-specific binding capacities.
Infectious diseases frequently induce the expression of
neoglycoprotein-reactive determinants, whereas nonin-
fectious inflammatory diseases such as autoimmune dis-
orders, drug reactions or to some part sarcoidosis are
accompanied by the ‘normal’ status of carbohydrate-bind-
ing capacities, i.e. negative ligandohistochemical reac-
tions [3, 21–23]. Immunosuppressive substances appear
to improve the course of diseases accompanied by a lack
of receptor expression [3, 21]. The recurrent hemoptysis
stopped when cyclophosphamide was applied. This re-
sponse of an idiopathic pulmonary hemosiderosis to cy-
clophosphamide has been reported in several cases [3, 11,
14, 23].
In contrast to the still unknown etiology of the so-called
idiopathic pulmonary hemosiderosis, this young patient
inhaled pesticides 3 days prior to the onset of the disease.
Jarvis et al. [24] investigated a cluster of cases with pul-
monary hemosiderosis in infants and could isolate the
toxigenic fungus Memnoniella echinata which produces
two cytotoxic trichothecene mycotoxins. In our case, the
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applied pesticide substances can be characterized as syn-
thetic peritroids (deltamethrin, bensultap and cyhalotrin).
They have been reported to be irritating for the skin and
respiratory system [25]. Deltamethrin can induce pares-
thesias and tremor, whereas bensultap can lead to in-
creased secretion from the nose, eyes and mouth as well as
diarrhea in mammals. These substances have been
grouped into the toxicity classes III and IV, respectively,
which correspond to a lethal dose LD50 of 50–500 mg/kg
(class III) and 500–2,000 mg/kg (class IV; mg substance/
body weight) in mice according to the Swiss toxicity grad-
ing, or according to poisonous (class III) or harmful (class
IV) substances in the German or European scheme.
Whether their inhalation will have a direct impact on the
vascular and immune systems which can lead to the
observed severe bleeding, or whether it is only able to
aggravate an already established lesion in the respiratory
system, remains to be unequivocally established. The
close association in time and space between the clearly
documented inhalation of the toxic substances and the
onset of the bleeding justifies to assume a more than phe-
nomenological correlation between exposure to the exoge-
nous noxae, whose individual impacts can presently not
be laid down beyond any doubt, and the clinical manifes-
tation of the so-called idiopathic hemosiderosis. There-
fore, a thorough clinical history is mandatory in cases
with pulmonary hemosiderosis.
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